Dagmar Koethe
Impact in
- Biological Psychiatry top 0.2%
- Tryptophan and brain disorders
- Pharmacology top 0.1%
- Cannabis and Cannabinoid Research
Papers in
- Pharmacology 29
- Cannabis and Cannabinoid Research 29
-
- Schizophrenia research and treatment 8
- Bipolar Disorder and Treatment 6
- Co-authors
- F. Markus Leweke (52 shared papers)C.W. Gerth (13 shared papers)Joachim Klosterkötter (15 shared papers)Daniele Piomelli (9 shared papers)Martin Hellmich (14 shared papers)Daniela Schreiber (13 shared papers)Carolin Hoyer (5 shared papers)Franziska Pahlisch (7 shared papers)
- Journals
- European Archives of Psychiatry and Clinical Neuroscience (6 papers)Schizophrenia Research (5 papers)Molecular Psychiatry (4 papers)European Psychiatry (3 papers)BMJ Open (3 papers)
- Partner nations
- GermanyAustraliaUnited Kingdom
In The Last Decade
Dagmar Koethe
64 papers receiving 4.5k citations
Dagmar Koethe's Hit Papers
Peers
Comparison fields: 5 of 134
- Biological Psychiatry 728
- Pharmacology 2.2k
- Cellular and Molecular Neuroscience 1.2k
- Psychiatry and Mental health 716
- Behavioral Neuroscience 161
Countries citing papers authored by Dagmar Koethe
This map shows the geographic impact of Dagmar Koethe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Koethe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Koethe more than expected).
Fields of papers citing papers by Dagmar Koethe
This network shows the impact of papers produced by Dagmar Koethe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Koethe. The network helps show where Dagmar Koethe may publish in the future.
Co-authors
The 25 scholars most cited alongside Dagmar Koethe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia Hit paper breakdown → | 2012 | 801 |
| 2 | 2004 | 374 | |
| 3 | 2006 | 230 | |
| 4 | 2007 | 181 | |
| 5 | 2004 | 175 | |
| 6 | 2008 | 162 | |
| 7 | 2008 | 157 | |
| 8 | 2019 | 149 | |
| 9 | 2006 | 144 | |
| 10 | 2019 | 143 | |
| 11 | 2007 | 138 | |
| 12 | 2009 | 131 | |
| 13 | 2018 | 122 | |
| 14 | 2002 | 118 | |
| 15 | 2007 | 115 | |
| 16 | 2007 | 109 | |
| 17 | 2002 | 96 | |
| 18 | 2009 | 92 | |
| 19 | 2013 | 83 | |
| 20 | 2010 | 79 |
About Dagmar Koethe
Dagmar Koethe is a scholar working on Pharmacology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience, having authored 64 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (29 papers), Schizophrenia research and treatment (8 papers), Neurotransmitter Receptor Influence on Behavior (7 papers), Tryptophan and brain disorders (7 papers), Bipolar Disorder and Treatment (6 papers), Neuroscience and Neuropharmacology Research (5 papers), Sleep and Wakefulness Research (5 papers) and Diet, Metabolism, and Disease (3 papers). The work is most often cited by research in Biological Psychiatry (728 citations), Pharmacology (2.2k citations), Cellular and Molecular Neuroscience (1.2k citations), Psychiatry and Mental health (716 citations) and Behavioral Neuroscience (161 citations). Dagmar Koethe has collaborated with scholars based in Germany, Australia and United Kingdom. Frequent co-authors include F. Markus Leweke, C.W. Gerth, Joachim Klosterkötter, Daniele Piomelli, Martin Hellmich, Daniela Schreiber, Carolin Hoyer, Franziska Pahlisch, Andrea Giuffrida and Laura Kranaster. Their work appears in journals such as European Archives of Psychiatry and Clinical Neuroscience, Schizophrenia Research, Molecular Psychiatry, European Psychiatry and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.